Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Budesonide (0.5mg) + Formoterol (20mcg) Respule
Therapeutic Category
Asthma, Pulmonary, Respiratory
Dosage Form
Respule
Packaging Type
Pack
Packaging
4*5*2.5ml
Price
₹400/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Budesonide 0.5mg + Formoterol 20mcg respule is a combination inhalation therapy used for the effective management of asthma and COPD, improving airflow and reducing respiratory symptoms.
Budesonide acts as a potent anti-inflammatory corticosteroid, controlling airway inflammation, while Formoterol provides long-acting bronchodilation, relaxing bronchial smooth muscles and facilitating easier breathing.
This respule is commonly prescribed for maintenance therapy in asthma patients, chronic bronchitis, and COPD, helping prevent exacerbations and improve overall pulmonary function.
With proven clinical efficacy, dual-action mechanism, and patient-friendly dosing, this formulation strengthens a respiratory therapy portfolio and supports consistent demand in chronic pulmonary care.
Common side effects may include throat irritation, hoarseness, cough, oral thrush, tremors, or mild palpitations. Rarely, systemic corticosteroid effects or cardiovascular effects may occur with prolonged use.
Buditerm F Respule is indicated for the maintenance treatment of asthma, chronic bronchitis, and COPD. It helps in preventing bronchospasm, controlling inflammation, and improving lung function, as prescribed by a healthcare professional.
For inhalation use only. Use under strict medical supervision. Not intended for acute asthma attacks; a rescue inhaler should be used for sudden symptoms. Rinse mouth after each use to prevent oral infections.
Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of reach of children.
Composition : Budesonide (0.5mg) Respule
Composition : Budesonide (200mcg) + Formoterol (6mcg) Rota Capsule
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
Composition : Formoterol 6mcg + Budesonide 400mcg Rota Capsule
Composition : Formoterol (6mcg) + Budesonide (400mcg) Inhaler
Composition : Levosalbutamol (1.25mg) + Budesonide (0.5mg) Respule
Composition : Fluticasone Furoate (27.5mcg) + Azelastine (140mcg)
Composition : Fluticasone Propionate 250mcg + Formoterol Fumarate 6mcg Life Cap
Composition : Fluticasone Furoate (27.5mcg)
Composition : Fluticasone Propionate (0.005% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Budesonide combined with Formoterol has strong demand in the respiratory and critical care segment, making it a high-value product for pharma distributors, wholesalers, and franchise partners. It is widely used for asthma, COPD exacerbations, wheezing, and chronic respiratory inflammation, ensuring steady prescription-driven demand in hospitals and clinics.
Medical distributors and agencies benefit from the high and continuous demand in respiratory therapy, especially in emergency and chronic care settings. Combination of anti-inflammatory + long-acting bronchodilator action Used in asthma control and COPD maintenance therapy Commonly prescribed in nebulization therapy for acute breathing difficulty Widely used by pulmonologists, emergency physicians, and hospitals Strong demand in ICU, emergency, and respiratory wards Important in long-term disease management and acute exacerbations This makes it a core respiratory critical-care product with strong hospital-driven demand.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Budesonide + Formoterol Respules with monopoly rights, promotional support, quality manufacturing standards, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and franchise partners benefit from strong hospital and pulmonology prescription flow, recurring respiratory patient demand, high usage in emergency cases, and stable year-round turnover in the respiratory segment.
Interested distributors, stockists, and pharma franchise partners can contact Cafoli LifeCare Pvt Ltd to discuss monopoly territory rights, pricing structure, marketing support, and complete respiratory critical-care product portfolio access to build a strong presence in the pulmonology and hospital care market.